Totally Implantable Intravenous Device (TIVAD) Market size was valued at USD 1.2 Billion in 2024 and is forecasted to grow at a CAGR of 9.5% from 2026 to 2033, reaching USD 2.5 Billion by 2033.
South Korea’s Totally Implantable Intravenous Device (TIVAD) Market: Types, Industry Demands, and Growth Factors
The Totally Implantable Intravenous Device (TIVAD) Market in South Korea is witnessing notable growth, driven by the rising prevalence of chronic diseases and advancements in medical technologies. TIVADs, commonly known as port-a-caths, are essential for patients requiring long-term intravenous therapies, such as chemotherapy or parenteral nutrition.
Market Dynamics and Industry Requirements
Device Types: The market primarily includes single-lumen and double-lumen ports, constructed from materials like titanium and plastic. These devices are designed for durability and patient comfort.
Applications: TIVADs are extensively used in oncology, hematology, and for patients with end-stage renal disease, facilitating repeated vascular access with reduced discomfort.
Industry Demands: Healthcare providers emphasize the need for devices that minimize infection risks, are easy to implant, and compatible with imaging technologies. Manufacturers are focusing on developing TIVADs with antimicrobial coatings and improved biocompatibility.
Regulatory Landscape
In South Korea, medical devices, including TIVADs, are regulated by the Ministry of Food and Drug Safety (MFDS). Manufacturers must adhere to stringent approval processes, ensuring device safety and efficacy. Compliance with Good Manufacturing Practices (GMP) and ISO 13485 standards is mandatory for market entry.
Market Growth and Opportunities
Technological Advancements: Innovations such as MRI-compatible ports and catheter-tip positioning systems enhance device functionality and patient outcomes.
Home-Based Care: The shift towards outpatient treatments increases the demand for user-friendly TIVADs suitable for home care settings.
Aging Population: South Korea's growing elderly demographic contributes to the rising need for long-term intravenous therapies, propelling market growth.
As the healthcare landscape evolves, the TIVAD market in South Korea is poised for continued expansion, with industry stakeholders focusing on innovation, regulatory compliance, and meeting the specific needs of both healthcare providers and patients.
Get an In-Depth Research Analysis of the South Korea Totally Implantable Intravenous Device (TIVAD) Market Size And Forecast [2025-2032]
C.R. Bard
AngioDynamics
Smiths Medical
Bard Access Systems
B. Braun
Teleflex
Cook Medical
Fresenius Kabi
PFM Medical
Vygon
Districlass
PakuMed
MedComp
Navilyst Medical
Norfolk Medical Products
Suzhou Linhwa Medical Devices
Weigao Holding
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Totally Implantable Intravenous Device (TIVAD) Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Totally Implantable Intravenous Device (TIVAD) Market
Single-Lumen TIVAD
Double-Lumen TIVAD
Triple-Lumen TIVAD
Silicone
Polyurethane
Composite Materials
Oncology
Hematology
Antibiotic Therapy
Nutrition Therapy
Hospitals
Outpatient Surgical Centers
Home Healthcare Settings
Specialized Clinics
Direct Sales
Third-Party Distributors
Online Sales
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Totally Implantable Intravenous Device (TIVAD) Market Research Analysis
1. Introduction of the South Korea Totally Implantable Intravenous Device (TIVAD) Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Totally Implantable Intravenous Device (TIVAD) Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Totally Implantable Intravenous Device (TIVAD) Market, By Type
6. South Korea Totally Implantable Intravenous Device (TIVAD) Market, By Application
7. South Korea Totally Implantable Intravenous Device (TIVAD) Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Totally Implantable Intravenous Device (TIVAD) Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/